|Articles|August 1, 2017
- Pharmaceutical Executive-08-01-2017
- Volume 37
- Issue 8
Pharmaceutical Executive, August 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Health Policy Problem Solver: Fumie Griegoalmost 9 years ago
Dealmaking in 2017: Striking a Balancealmost 9 years ago
Beyond the Science: Commercial Implications From ASCO 2017about 9 years ago
News Spotlight: Pharmaabout 9 years ago
Pharma’s Marijuana Makeoverabout 9 years ago
The 'Hear' and Now for Pharma and Social Mediaabout 9 years ago
Pressure Mounts on FDA, Pharma to Tackle Opioid Abuseabout 9 years ago
Syncing Social Media With Value-Care Modelabout 9 years ago
AI-based Social Listening as Aid to Pharmacovigilanceabout 9 years ago
Country Report: IndonesiaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5